SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Enzo Biochemical Inc. A biotechnology Co. with earnings.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ralph Misitano who started this subject9/12/2000 3:38:08 PM
From: greedsgd_2000   of 184
 
anyone have any thoughts on this post? While I noted and posted the CALPERS new 500 million core biotech (see Biotech valuation thread) allocation -I cannot confirm this connection.

YAHOO ENZ BOARD
re: ENZ - and CALPERS dollars
by: buffpooh 9/12/00 11:53 am
Msg: 37080 of 37102

Ladies and Gentlemen

The CALPERS story and the initiation of coverage by UBS are related.

CALPER's Investment Advisor and Asset Manager is Brinson Asset Management of Chicago IL.

In 1996 Brinson became a 100% subsidiary of Swiss Bank who later merged with UBS. Gary Brinson the founder of Brinson is on the board of UBS Warburg.

This is very good news as Brinson has an excellent track record.


Posted as a reply to: Msg 37072 by gdvmarch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext